×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download Now

EU approves contentious Alzheimer's medication

The European Union on Thursday approved the highly contentious Alzheimer's medication Kisunla under strict conditions, with the drug's effectiveness hotly debated by the medical community.

Get Full Access for Ksh299/Week
Unlock the Full Story — Join Thousands of Informed Kenyans Today
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in